Long-term effects of therapeutic vaccination with rgp 120.
Lindenburg
K
K
Langendam
M W
MW
Veenstra
J
J
Miedema
F
F
Coutinho
R
R
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000628:therapy*; D018791:CD4 Lymphocyte Count; D005500:Follow-Up Studies; D015699:HIV Envelope Protein gp120 / Q000627:therapeutic use*; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use; D013997:Time Factors; D014614:Vaccines, Synthetic / Q000627:therapeutic use; D014765:Viral Vaccines / Q000627:therapeutic use*
D015699:HIV Envelope Protein gp120; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic; D014765:Viral Vaccines